Effect of Growth State on Transcription Levels of Genes Encoding Major Secreted Antigens of Mycobacterium tuberculosis in the Mouse Lung

Infection and Immunity

Volumn 72, Issue 4, 2004, Pages 2420-2424

  Shi, Lanbo ^a   North, Robert ^b   Gennaro, Maria Laura ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; INFECTION COMPLICATION; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RNA ANALYSIS;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; INTERFERON TYPE II; LIPOPROTEINS; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; TRANSCRIPTION, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 1842587995     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.4.2420-2424.2004     Document Type: Article

References (43)

1. Andersen, P. 1994. The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology 191:537-547.
2. Anderson, D. H., G. Harth, M. A. Horwitz, and D. Eisenberg. 2001. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (antigen 85B), a mycolyl transferase. J. Mol. Biol. 307:671-681.
3. Arend, S. M., P. Andersen, K. E. van Meijgaarden, R. L. Skjot, Y. W. Subronto, J. T. van Dissel, and T. H. Ottenhoff. 2000. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181:1850-1854.
4. BenAmor, Y., and M. L. Gennaro. 2002. Genomics as a tool for identifying secreted proteins in bacteria, p. 119-157. In A. Danchin (ed.), Genomics of GC rich gram-positive bacteria. Caister Academic Press, Wymondham, United Kingdom.
5. Benjamin, R. G., S. M. Debanne, Y. Ma, and T. M. Daniel. 1984. Evaluation of mycobacterial antigens in an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of tuberculosis. J. Med. Microbiol. 18:309-318.
6. Bloch, H., and W. Segal. 1955. Viability and multiplication of vaccines in immunization against tuberculosis. Am. Rev. Tuberc. Pulm. Dis. 71:228-248.
7. Bothamley, G. H. 1995. Serological diagnosis of tuberculosis. Eur. Respir. J. 20(Suppl. 8):676S-688S.
8. Bothamley, G. H., J. S. Beck, R. C. Potts, J. M. Grange, T. Kardjito, and J. Ivanyi. 1992. Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis. J. Infect. Dis. 166:182-186.
9. Bothamley, G. H., R. Rudd, F. Festenstein, and J. Ivanyi. 1992. Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax 47:270-275.
10. Brusasca, P. N., R. L. Peters, S. Motzel, H. Klein, and M. L. Gennaro. 2003. Antigen recognition by serum antibodies in non-human primates experimentally infected with Mycobacterium tuberculosis. Comp. Med. 53:165-172.
11. Chan, S. L., Z. Reggiardo, T. M. Daniel, D. J. Girling, and D. A. Mitchison. 1990. Serodiagnosis of tuberculosis using an ELISA with antigen 5 and a hemagglutination assay with glycolipid antigens. Results in patients with newly diagnosed pulmonary tuberculosis ranging in extent of disease from minimal to extensive. Am. Rev. Respir. Dis. 142:385-389.
12. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, H. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
13. Doherty, T. M., A. Demissie, J. Olobo, D. Wolday, S. Britton, T. Eguale, P. Ravn, and P. Andersen. 2002. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol. 40:704-706.
14. Dunn, P. L., and R. J. North. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:3428-3437.
15. Espitia, C., I. Cervera, R. Gonzalez, and R. Mancilla. 1989. A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. Clin. Exp. Immunol. 77:373-377.
16. Harboe, M. 1992. The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases. Int. J. Lepr. Other Mycobact. Dis. 60:470-476.
17. Harboe, M., and H. G. Wiker. 1992. The 38-kDa protein of Mycobacterium tuberculosis: a review. J. Infect. Dis. 166:874-884.
18. Horwitz, M. A., and G. Harth. 2003. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect. Immun. 71:1672-1679.
19. Jung, Y. J., R. LaCourse, L. Ryan, and R. J. North. 2002. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J. Exp. Med. 196:991-998.
20. Lyashchenko, K., R. Colangeli, M. Houde, H. A. Jahdali, D. Menzies, and M. L. Gennaro. 1998. Heterogeneous antibody responses in tuberculosis. Infect. Immun. 66:3936-3940.
21. McKinney, J. D., K. Honer zu Bentrup, E. J. Munoz-Elias, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. Jacobs, Jr., and D. G. Russell, 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738.
22. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-280.
23. Olsen, A. W., and P. Andersen. 2003. A novel TB vaccine; strategies to combat a complex pathogen. Immunol. Lett. 85:207-211.
24. Orme, I. M. 1988. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:3310-3312.
25. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167:5217-5225.
26. Pollock, J. M., and P. Andersen. 1997. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J. Infect. Dis. 175:1251-1254.
27. Ravn, P., A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H. A. Amoudy, A. S. Mustafa, A. K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, F. von Reyn, and P. Andersen. 1999. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645.
28. Renshaw, P. S., P. Panagiotidou, A. Whelan, S. V. Gordon, R. G. Hewinson, R. A. Williamson, and M. D. Carr. 2002. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6/CFP-10 complex. Implications for pathogenesis and virulence. J. Biol. Chem. 277:21598-21603.
29. Ronning, D. R., T. Klabunde, G. S. Besra, V. D. Vissa, J. T. Belisle, and J. C. Sacchettini, 2000. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat. Struct. Biol. 7:141-146.
30. Segal, W. 1984. Growth dynamics of in vivo and in vitro grown mycobacterial pathogens, p. 547-573. In G. P. Kubica and L. G. Wayne (ed.), The mycobacteria. A sourcebook. Marcel Dekker, Inc., New York, N.Y.
31. Shi, L., Y.-J. Jung, S. Tyagi, M. L. Gennaro, and R. North. 2003. Expression of Th1-mediated immunity in mouse lung induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc. Natl. Acad. Sci. USA 100:241-246.
32. Silva, V. M. C., G. Kanaujia, M. L. Gennaro, and D. Menzies. 2003. Factors associated with humoral response to ESAT-6, 38kDa and 14kDa antigens in patients with a spectrum of tuberculosis. Int. J. Tub. Lung Dis. 7:478-484.
33. Sørensen, A. L., S. Nagai, G. Houen, P. Andersen, and Å. B. Andersen. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63:1710-1717.
34. Stroebel, A. B., T. M. Daniel, J. H. Lau, J. C. Leong, and H. Richardson. 1982. Serologic diagnosis of bone and joint tuberculosis by an enzyme-linked immunosorbent assay. J. Infect. Dis. 146:280-283.
35. Turneer, M., J. P. Van Vooren, J. De Bruyn, E. Serruys, P. Dierckx, and J. C. Yernault. 1988. Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen of Mycobacterium bovis bacillus Calmette-Guerin. J. Clin. Microbiol. 26:1714-1719.
36. Tyagi, S., D. P. Bratu, and F. R. Kramer. 1998. Multicolor molecular beacons for allele discrimination. Nat. Biotechnol. 16:49-53.
37. Tyagi, S., and F. R. Kramer. 1996. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14:303-308.
38. Tyagi, S., S. A. Marras, and F. R. Kramer. 2000. Wavelength-shifting molecular beacons. Nat. Biotechnol, 18:1191-1196.
39. Ulrichs, T., P. Anding, S. Porcelli, S. H. Kaufmann, and M. E. Munk. 2000. Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect. Immun. 68:6073-6076.
40. Vyas, N. K., M. N. Vyas, and F. A. Quiocho. 2003. Crystal structure of M. tuberculosis ABC phosphate transport receptor: specificity and charge compensation dominated by ion-dipole interactions. Structure (Camb) 11:765-774.
41. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
42. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 56:648-661.
43. Wilkins, E. G. L. 1994. The serodiagnosis of tuberculosis, p. 367-380. In P. D. O. Davies (ed.), Clinical tuberculosis. Chapman and Hall Medical, London, United Kingdom.